Hormonal methods for emergency contraception

被引:0
|
作者
Li, Raymond Hang Wun [1 ,2 ]
Lo, Sue Seen Tsing [1 ,2 ]
Cameron, Sharon Tracey [3 ,4 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Sch Clin Med, Dept Obstet & Gynaecol,Pokfulam, 102 Pokfulam Rd, Hong Kong, Peoples R China
[2] Family Planning Assoc Hong Kong, Wan Chai, 10th Floor,130 Hennessy Rd, Hong Kong, Peoples R China
[3] NHS Lothian, Chalmers Sexual Hlth Ctr, 2a Chalmers St, Edinburgh EH3 9ES, Scotland
[4] Univ Edinburgh, Ctr Reprod Hlth, Edinburgh BioQuarter, Edinburgh EH16 4UU, Scotland
关键词
Hormonal emergency contraception; Levonorgestrel; Ulipristal acetate; Mifepristone; Cyclo-oxygenase inhibitors; HUMAN FALLOPIAN-TUBE; ULIPRISTAL ACETATE; IN-VITRO; YUZPE REGIMEN; ONLY PILL; LEVONORGESTREL; MIFEPRISTONE; PREGNANCY; WOMEN; ATTACHMENT;
D O I
10.1016/j.bpobgyn.2024.102550
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The World Health Organization includes oral emergency contraception (EC) in the list of essential medicines. Ulipristal acetate (UPA) and levonorgestrel (LNG) are the recommended oral methods. UPA has superior efficacy and a comparable side effect profile compared with LNG. Both work by inhibiting or delaying ovulation, so that sperm present in the reproductive tract will have lost their fertilising ability by the time the oocyte is eventually released. Neither LNG nor UPA at the EC doses have significant effects on the endometrium and are unable to prevent implantation. Mifepristone can also be used for EC but its availability is limited to few countries. LNG is less effective in women with a body mass index over 26 kg/m2 or weight over 70 kg. Hormonal contraception can be quickstarted immediately following LNG, or five days following UPA. LNGreleasing intrauterine devices and cyclo-oxygenase inhibitors are promising options for EC to be further studied.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The history of emergency contraception
    Kolanska, Kamila
    Faucher, Philippe
    Darai, Emile
    Bouchard, Philippe
    Chabbert-Buffet, Nathalie
    M S-MEDECINE SCIENCES, 2021, 37 (8-9): : 779 - 784
  • [22] Emergency contraception - A review
    Rudzinski, Patryk
    Lopuszynska, Inga
    Pazik, Dorota
    Adamowicz, Dominik
    Jargielo, Anna
    Cieslik, Aleksandra
    Kosieradzka, Karolina
    Stanczyk, Justyna
    Meliksetian, Astrik
    Wosinska, Alicja
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2023, 291 : 213 - 218
  • [23] Update on emergency contraception
    Fok, Wing Kay
    Blumenthal, Paul D.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2016, 28 (06) : 522 - 529
  • [24] Starting hormonal contraception after using emergency contraception: what should we recommend?
    Glasier, Anna
    HUMAN REPRODUCTION, 2015, 30 (12) : 2708 - 2710
  • [25] Research and development of emergency contraception over five decades
    Li, Raymond Hang Wun
    Ho, Pak Chung
    Glasier, Anna
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2025,
  • [26] Effect of levonorgestrel emergency contraception on implantation and fertility: A review
    Endler, M.
    Li, R. H. W.
    Danielsson, K. Gemzell
    CONTRACEPTION, 2022, 109 : 8 - 18
  • [27] Ulipristal Acetate A Review of Its Use in Emergency Contraception
    McKeage, Kate
    Croxtall, Jamie D.
    DRUGS, 2011, 71 (07) : 935 - 945
  • [28] Emergency contraception: clinical outcomes
    Glasier, Anna
    CONTRACEPTION, 2013, 87 (03) : 309 - 313
  • [29] EMERGENCY CONTRACEPTION: AN UPDATED REVIEW
    Guida, M.
    Marra, M. L.
    Palatucci, V.
    Pascale, R.
    Visconti, F.
    Zullo, F.
    TRANSLATIONAL MEDICINE AT UNISA, 2011, 1 : 271 - 294
  • [30] Emergency contraception:What is new?
    Sefa Kelekci
    Serpil Aydogmus
    World Journal of Obstetrics and Gynecology, 2015, (04) : 95 - 101